How to find data

Select the required Time Period using the filter above
Choose the Commodity you need using the search bar or navigation tree (6,000+ items)
Select the Reporter, Partner and Trade Flow you want
Choose the visualization type
Customize your table or chart using the Settings button
Save your results as an image or data file using the Download button

Canada | Imports and Exports | World | Glands and other organs for organo-therapeutic uses, dried,heparin and its salts | Value (US$) and Value Growth, YoY (%) | 2012 - 2023

TABLE

LINE

COLUMN

PIE

MAP

Settings

Save query

Download

PNG
JPG
SVG

XLSX
XLSX (flat table)
XLSX (time series)

The value of exports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." from Canada totalled $ 34 million in 2023. Sales of commodity group 3001 from Canada decreased by 9.49% in value terms compared to 2022. exports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." decreased by $ 3.59 million (cumulative exports of commodity group 3001 from Canada amounted $37 million in 2022)

Exports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." amounted to 0.006% of total exports from Canada (cumulative merchandise exports from Canada totalled $ 566 billion in 2023). The share of commodity group 3001 in total exports from Canada decreased by 0 p.p. compared to 2022 (it was 0.006% in 2022 and cumulative exports from Canada were equal to $ 596 billion).

Exports of commodity group 3001 amounted to 0.356% of total sales of group "" from Canada in 2023 (the value of exports of commodity group from Canada amounted to $9.58 billion in 2023). The share of exports of commodity group 3001 in sales of commodity group from Canada increased by 0.004 p.p. compared to 2022 (it was 0.352% in 2022, and exports of commodity group from Canada were $10.7 billion).

Exports | Canada | 3001

Export destinations of 3001 Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s. from Canada

Open

Where does Canada export Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.?

Top export destinations of "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." from Canada in 2023:

USA with a share of 89% (30 million US$)
Iran with a share of 2.79% (956 thousand US$)
Saudi Arabia with a share of 1.91% (656 thousand US$)
Other Asia, nes with a share of 1.36% (465 thousand US$)
United Arab Emirates with a share of 1.14% (390 thousand US$)
Israel - 264 thousand US$
Qatar - 209 thousand US$
Bermuda - 135 thousand US$
Singapore - 99 thousand US$
France - 92 thousand US$

Exports structure of 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s. - from Canada in 2023 represented by the following main commodity groups:

82% (28 million US$): 300190 - Heparin & its salts; other human/animal subs. prepared for therapeutic/prophylactic uses, n.e.s. in heading 3001
17.2% (5.9 million US$): 300120 - Extracts of glands, other organs or of their secretions, for organo-therapeutic uses

The value of imports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." to Canada totalled $ 106 million in 2023. Sales of commodity group 3001 to Canada went up by 11.5% compared to 2022: imports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." went up by $ 10.9 million (the value of imports of commodity group 3001 to Canada was equal to $95 million in 2022)

Imports of commodity group 3001 "Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s." accounted for 0.019% of total import flow to Canada (in 2023, total imports to Canada amounted to $ 558 billion). The share of commodity group 3001 in total imports to Canada increased by 0.002 p.p. compared to 2022 (it was 0.016% in 2022 and cumulative imports to Canada were equal to $ 569 billion).

Imports of commodity group 3001 reached 0.562% of total imports of group "" to Canada in 2023 (imports of commodity group to Canada totalled $18.8 billion in 2023). The share of purchases of commodity group 3001 in total imports of commodity group to Canada increased by 0.087 p.p. compared to 2022 (it was 0.474% in 2022, and imports of commodity group to Canada accounted for $20 billion).

Imports | Canada | 3001

Sources of imports of 3001 Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s. for Canada